Replimune Group, Inc. (REPL)
15.60
-0.28
(-1.76%)
USD |
NASDAQ |
Aug 27, 16:00
15.60
0.00 (0.00%)
After-Hours: 20:00
Replimune Group EPS Diluted (TTM) : -3.279 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.279 |
| March 31, 2026 | -3.506 |
| December 31, 2025 | -3.582 |
| September 30, 2025 | -3.608 |
| June 30, 2025 | -3.379 |
| March 31, 2025 | -3.209 |
| December 31, 2024 | -3.144 |
| September 30, 2024 | -3.116 |
| June 30, 2024 | -3.343 |
| March 31, 2024 | -3.312 |
| December 31, 2023 | -3.284 |
| September 30, 2023 | -3.203 |
| June 30, 2023 | -3.088 |
| March 31, 2023 | -3.121 |
| December 31, 2022 | -2.922 |
| September 30, 2022 | -2.803 |
| June 30, 2022 | -2.580 |
| March 31, 2022 | -2.326 |
| December 31, 2021 | -2.119 |
| Date | Value |
|---|---|
| September 30, 2021 | -1.992 |
| June 30, 2021 | -1.885 |
| March 31, 2021 | -1.798 |
| December 31, 2020 | -1.767 |
| September 30, 2020 | -1.790 |
| June 30, 2020 | -1.685 |
| March 31, 2020 | -1.547 |
| December 31, 2019 | -1.326 |
| September 30, 2019 | -1.105 |
| June 30, 2019 | -1.016 |
| March 31, 2019 | -1.032 |
| December 31, 2018 | -1.036 |
| September 30, 2018 | -0.93 |
| June 30, 2018 | -0.8134 |
| March 31, 2018 | -0.6096 |
| December 31, 2017 | -0.516 |
| September 30, 2017 | -0.3793 |
| June 30, 2017 | -0.233 |
| March 31, 2017 | -0.1214 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Moderna, Inc. | -7.985 |
| Kalaris Therapeutics, Inc. | -2.014 |
| Arrowhead Pharmaceuticals, Inc. | -2.243 |
| Oncolytics Biotech, Inc. | -0.2725 |
| Sangamo Therapeutics, Inc. | -0.383 |